EXECUTIVES

Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board

Dr. Heather Landau is the Director of Amyloidosis Program and [...]

By |2023-08-18T17:07:38+00:00August 18, 2023|3rd Party Medical Device Industry News|Comments Off on Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board
Go to Top